NPY and pheochromocytoma: Despite the measurement of catecholamines displaying a higher sensitivity in pheochromocytoma and paraganglioma, NPY may be a viable alternative in patients suffering from kidney impairment or under treatments that interfere with catecholamine reuptake [79].